(19)
(11) EP 4 519 263 A1

(12)

(43) Date of publication:
12.03.2025 Bulletin 2025/11

(21) Application number: 23724723.4

(22) Date of filing: 03.05.2023
(51) International Patent Classification (IPC): 
C07D 471/04(2006.01)
A61K 31/437(2006.01)
 A61P 25/28(2006.01)
(52) Cooperative Patent Classification (CPC):
C07D 471/04; A61P 25/28
(86) International application number:
PCT/EP2023/061588
(87) International publication number:
WO 2023/213836 (09.11.2023 Gazette 2023/45)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 05.05.2022 EP 22171914

(71) Applicant: Galapagos NV
2800 Mechelen (BE)

(72) Inventors:
  • KELGTERMANS, Hans
    3190 Boortmeerbeek (BE)
  • VAN DER SCHUEREN, Jan
    2800 Mechelen (BE)
  • PESIC, Dijana
    10000 Zagreb (HR)
  • ROSCIC, Maja
    10000 Zagreb (HR)
  • JURKOVIC, Mihaela
    10000 Zagreb (HR)

(74) Representative: Bar, Grégory 
Galapagos NV IP Department Generaal De Wittelaan, L11 A3
2800 Mechelen
2800 Mechelen (BE)

   


(54) SULFONAMIDE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS